Upper Tract Carcinoma Flashcards

1
Q

What is the ddx of a ureteral mass?

A

tumor (enhancement with contrast, concern for UC)

fungus ball

blood clot

obstructing papillae

radiolucent stone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is standard workup of upper tract UC?

A
  1. CT A/P (Urogram)→assess filling defects and RP adenopathy
  2. Cysto → initial screen for hematuria
  3. RGP → confirm filling defects in pelvis or ureter, can send aspirate or barbotage for cytology
  4. URS → direct vision and bx or brushing
  5. Antegrade pyelography → if retrograde fails
  6. Nephroscopy → endoscopic eval and mgmt. of selected low-grade tumors by fulguration and/or resection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Treatment options for ureteral tumor?

A
  1. Nephroureterectomy with cuff of bladder

Indications: normal contralateral kidney and high -grade tumor or uncontrollable local recurrences

*High grade ureteral and pelvic tumors unsuitable for local resection should undergo radical surgical extirpation +/- NAC or adjuvant chemo

*If bilateral or solitary kidney, may be necessary for renal txp (wait 2 years)

  1. Segmental resection

Indications: conservative measure (e.g. segmental resection or endoscopic treatment) are indicated when preservation of renal function is mandatory (e.g. low-stage b/l dz, azotemia, solitary kidney) or low grade lesions

*Distal ureteral excision with removal of bladder cuff and reimplant is best option

*Proximal excision and anastomosis not ideal for very distal, reserved for mid to proximal ureteral tumors

  1. Ureteroscopy and resection or fulguration

Indications: distal ureter or not candidates for major surgery due to comorbidities, risk of ureteral stricture, perforation, and high rates of recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the utilization of Mitomycin C in upper tract UC?

A

Can be given intravesically after nephroureterectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe epidemology of upper tract UC:

A

comprises 5-10 % of all UC

majority present at higher stage compared to bladder

average age at dx slightly older

Gender disparity less compared to bladder, M:F → 2:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk factor for UC of upper tract?

A

Same as bladder (tobacco, chemical carcinogens, analgesics, chronic inflammation/infection)

  1. Balkan Nephropathy: interstitial nephritis causing renal insufficiency, possible consumption of contaminated wheat (aristolochia), 100-200 x higher risk, also in herbal remedies
  2. Lynch syndrome: AD DNA mismatch repair increasing risk of colorectal and endometrial; lifetime risk 10-15%
  3. Arsenic
  4. History of bladder UC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Relationship between upper tract and bladder UC?

A
  1. Chance of UTUC after bladder UC ~5%, but 15-20% of pts with UTUC have hx of bladder ca
  2. highest for patient with CIS or HG
  3. hx of UC at trigone or bladder neck
  4. hx of multifocal bladder ca
  5. VUR
  6. UC at ureteral margin or distal ureters during cystectomy
  7. after UTUC probability of bladder ca 50-70%
  8. probability of UC in contralateral side 2-5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is ddx of calyceal or pelvic collecting system mass?

A

radiolucent stone

blood clot

fungus ball

papillary necrosis

tumor

complex/peripelvic cyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment option for renal/pelvic UC?

A
  1. Nephroureterectomy with bladder cuff
  2. Segmental resection or local excision
    1. Open pyelotomy with tumor excision/fulguration
    2. appropriate for select low grade, low stage tumors in both kidney or solitary kidney with poor GFR (not best option)
  3. Partial nephrectomy: where renal failure must be avoided (not best option)
  4. Ureteroscopic resection and/or fulguration
    1. Vigilant follow up and repeat URS
    2. Good for small, noninvasive Ta, or poor functional status
  5. Percutaneous treatment
    1. Advantage is facilitating tumor removal and instillation of anti-tumor meds via PCN
    2. Risks: bleeding, tumor spillage, tumor implantation
    3. Small, solitary tumors not accessible by URS, can consider laser
  6. Instillation therapy
    1. Multiple superficial tumors or CIS with b/l or CKD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is surveillance after URS resection/fulguration?

A

Cysto and ipsilateral (tumor side) URS q 6 mo for 3 years then annually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name a diabetic medicine that can increase risk of UC?

A

Pioglitozone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Any medications that can interfere with treatment efficacy of high grade protocols for all UC?

A

Warfarin can decrease efficacy of BCG (but studies equivocal, rarely stopped)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some additional treatment options for high grade/invasive UTUC?

A
  1. Radiation therapy: best used for local control and adjuvant or palliative therapy
  2. Angioinfarction: symptomatic patients with incurable distant mets or not candidate for Nx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe follow up after nephroureterectomy for UTUC for a HG invasive lesion?

A

cysto: q 3 mo x 2 years, q 6 mo x 2 years, then q year
cytology: q3 mo x 2 years, q 6 mo x 2 years, the q year

CTU: q 3-6 mo x 2 years, then discretion

CXR: q6 mo x 2 years, then discretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Staging of UTUC:

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Proposed risk classification from EAU for UTUC:

A